https://www.tempus.com/publications/ongoing-partial-response-at-6-months-to-olaparib-for-metastatic-melanoma-with-somatic-palb2-mutation-after-failure-of-immunotherapy-a-case-report/ AI-enabled precision medicine Fri, 07 Oct 2022 20:11:50 +0000 hourly 1